AUPH
Aurinia Pharmaceuticals Inc
15.80$
-0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.3% | +11.5% | +13.7% | +18.5% | -11.7% | +4.3% | +12.1% | +4.9% | +5.0% | +0.8% | +7.1% | – | |
| – | -20.3% | +43.7% | +14.9% | -32.3% | -8.0% | +54.4% | -17.0% | +19.5% | -0.4% | -23.2% | +0.8% | – | |
| – | -16.9% | +7.2% | +13.5% | +27.9% | -12.0% | -0.8% | +16.7% | +3.3% | +5.7% | +3.7% | +7.7% | – | |
| – | -24.8% | -45.7% | -26.5% | -25.3% | +166.1% | -29.2% | +29.4% | +13.5% | +29.2% | -31.4% | +74.7% | – | |
| – | +4.8% | -11.3% | -8.4% | -7.0% | -17.7% | -37.8% | +29.9% | +1.6% | +11.3% | -23.8% | +8.3% | – | |
| – | -5.8% | -11.7% | -6.5% | +0.4% | +12.0% | -42.8% | +33.6% | -17.7% | +0.5% | -15.9% | +1.8% | – | |
| – | – | – | – | – | -114.2% | – | -8.1% | +48.1% | +11.7% | +24.6% | +11.9% | – | |
| – | -6.4% | -2.1% | -6.6% | +0.8% | -5.1% | -6.9% | +4.7% | -1.6% | +492.7% | -84.5% | -6.3% | – | |
| – | – | – | – | +901.8% | -92.1% | +1,975.8% | -9.0% | +44.3% | +11.7% | +23.1% | +11.1% | – | |
| – | +54.0% | +61.0% | +2.3% | -39.6% | -156.0% | – | -36.0% | -36.1% | -42,704.4% | – | +18.8% | – | |
| – | – | – | – | +1,887.5% | -90.0% | +1,533.6% | -7.8% | +46.7% | +568.1% | -83.7% | +8.9% | – | |
| – | – | – | – | +178.1% | -65.7% | +321.6% | -7.1% | +30.9% | +27.8% | +5.7% | +9.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.